Developing a Robust Target Product Profile (TPP) for Successful Therapy Adoption

Tune into this webinar to learn how the Cell and Gene Therapy Catapult can improve your understanding of the characteristics of a target product profile (TPP) and learn how to create a robust TPP to increase the likelihood of successful adoption of your advanced therapy

Watch the Webinar

Please provide your details to gain access.

The Cell and Gene Therapy Catapult takes your data very seriously. By using this form you are consenting to the processing of your personal data as per ourprivacy policy.

The Cell and Gene Therapy Catapult (CGT Catapult) have recently released a TPP resource to help therapy developers navigate the process of developing a robust TPP. It acts as an ATMP developers guide to creating an evidence generation plan for successful therapy adoption.

Find the resource here to learn more about a TPP:

In this webinar, the CGT Catapult’s experts in market access, regulatory affairs and non-clinical strategy will talk through the resource, discussing the value of a TPP and how to approach building one. They will be joined on the panel by an industry collaborator, Rinri Therapeutics, who will give insights on how the TPP approach is helping shape the early-stage development of an innovative cell therapy.

Who should watch: Developers of cell and gene therapies in the preclinical or early clinical stage are encouraged to attend this webinar.